Skip to main content

Table 1 BRIDGE implementation outcomes

From: Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial

Dimension Metric
Reach (number of patients reached) • Identification of patients who may have inherited cancer susceptibility (Aim 1)
• Identification of patients by race/ethnicity and rural/frontier vs. urban (i.e., representativeness) (Aim 1)
• Uptake of genetic counseling and genetic testing by race/ethnicity and rural/frontier vs. urban (Aim 2)
Efficacy (impact on clinical outcomes) • Uptake of genetic counseling and genetic testing for genetic services delivery models (Aim 2)
• Adherence to cancer prevention and screening recommendations (Aim 3)
• Differences in impact of model by race/ethnicity and rural/frontier vs. urban (Aims 2 and 3)
Adoption (number of trial participants) • Proportion of patients in patient-directed arm who complete pre-test education and request genetic testing (Aim 2)
• Proportion of patients in enhanced standard care arm who complete pre-test counseling and request genetic testing (Aim 2)
Implementation (fidelity to protocol) • Patient response to patient portal messages (Aims 1 and 2)
• Completion of workflow by genetic counseling assistants and genetic counselors (Aim 2)
Maintenance (extent a program becomes institutionalized) • Use of the clinical decision support algorithms to identify patients after trial enrollment is complete
• Continued use of genetic services delivery models after the trial is complete